LAVAL, QC, Oct. 15 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. (“Neptune”) (NASDAQ.NEPT - TSX.V.NTB), is pleased to announce the appointment of a dynamic new Scientific Advisory Board (the “Advisory Board”), comprised of 5 renowned scientists.
Neptune believes that the combined knowledge and experience of the new members of the Advisory Board will significantly contribute to Neptune’s scientifically driven growth. Neptune feels privileged to build its new Scientific Advisory Board with a group of such distinguished scientists.
American College
“I feel extremely honoured to be working with such an eminent group of scientists and profiting from their guidance and valuable advice while developing and building our product pipeline and growing in the nutraceutical and pharmaceutical worlds” said Dr. Tina Sampalis, Vice-President Research and Business Development of Neptune.
About Neptune Technologies & Bioressources Inc.
Neptune Technologies & Bioressources Inc. develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract(TM)). Using its proprietary process, Neptune Technologies & Bioressources Inc. is strategically positioning itself in the nutraceutical and pharmaceutical health and wellness market. The Company develops and markets new formulas and new products for specific applications in high growth markets such the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products.
Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from the historical results, from any future results expressed, or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “expects,” “intends,” “anticipates,” “will,” or “plans” to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company’s reports and registration statements filed with the Securities and Exchange Commission.
CONTACT: US Contact: John Tsemberides, ROI Group LLC, (212) 495-0743,
john@roiny.com; Canada Contact: Grant Howard, The Howard Group, Toll free:
888-221-0915, infor@howardgroupinc.com, www.howardgroupinc.com; Company
Contact: Andre Godin, V.P Administration and Finance, Neptune Technologies
& Bioressources Inc., a.godin@neptunebiotech.com, www.neptunebiotech.com
